PrEP Demonstration Project among Women at Risk for HIV Infection
针对艾滋病毒感染风险女性的 PrEP 示范项目
基本信息
- 批准号:10002300
- 负责人:
- 金额:$ 23.71万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-01 至 2022-06-30
- 项目状态:已结题
- 来源:
- 关键词:AIDS preventionAddressAdherenceAdultAffectAfrican AmericanAlabamaAreaAwarenessBehavior TherapyCaringCause of DeathCenters for Disease Control and Prevention (U.S.)ClinicCommunication ToolsCommunitiesContinuity of Patient CareDataDeep SouthDevelopmentEducationEpidemicEvidence based interventionFamily PlanningFundingFutureGoalsHIVHIV InfectionsHIV diagnosisHIV riskHIV/STDHealthHealth ServicesHealthcareHigh Risk WomanIncidenceIndividualInterventionKnowledgeMethodsOutcomePersonsPopulationPreventionPrimary Health CareProcessProviderRandomizedReproductive HealthResearchRiskRuralSamplingScienceServicesSoutheastern United StatesTarget PopulationsTestingTimeUnderserved PopulationUnited States National Institutes of HealthWomanWomen&aposs HealthWorkagedcare seekingcondomscosteffectiveness measureethnic minority populationexperiencehealth care availabilityhealth disparityhigh riskimplementation scienceimplementation trialimprovedinfection rateinterestmalemen who have sex with menmicrobicidemultidisciplinarypatient-clinician communicationpost interventionpre-exposure prophylaxispreferencepreventracial and ethnicracial disparityrisk perceptionrural arearural countiesscreeningservice deliverystatisticssuccesstherapy designtoolunderserved rural areauptakeurban area
项目摘要
PROJECT SUMMARY
African-American (AA) women living in the Deep South are 10 times more likely to be infected with HIV than
white women. Traditional HIV prevention methods, including STI/HIV education, comprehensive behavioral
interventions, and provision of condoms have rendered minimal success in this population. HIV pre-exposure
prophylaxis (PrEP) has become a promising biomedical prevention tool, with over 90% efficacy as shown in
numerous trials. PrEP has the potential to curb incident HIV infection among at-risk women; however,
biomedical HIV prevention work in the US has generally focused on men who have sex with men, often
leaving women (particularly women of racial/ethnic minority status) underserved, and a disparity with respect
to HIV infection inadequately addressed. Implementation science projects are urgently needed to evaluate
and overcome barriers to PrEP awareness, uptake, adherence, and persistence in this population. The
objective of this application is to increase PrEP uptake among AA women at-risk for HIV-infection in the rural
South, specifically those seeking care at Federally Qualified Healthcare Centers (FQHC) in rural Alabama.
We will use a mixed-methods approach to adapt and pilot test a patient-provider communication tool from the
CDC PrEP toolkit that focuses on the first three steps of the PrEP cascade (e.g., recognizing HIV risk,
identifying as a PrEP candidate, and interested in PrEP) to increase PrEP uptake via referrals to local PrEP
clinics. Specifically, we propose: (1) to explore the HIV risk perceptions of AA women with recent PrEP use
(N=15-25), AA women who are candidates for PrEP (N=15-25), and providers (N=20) and identify
preferences around patient-provider communication about HIV risk and PrEP services that address the
needs of AA women; (2A) To systematically adapt a patient-provider communication tool to increase PrEP
uptake at two FQHCs in rural Alabama, using an iterative implementation process; and (2B). To assess the
feasibility, acceptability, and preliminary impact of the patient-provider communication intervention on PrEP
uptake among AA women and their providers in a pilot pre-/post-intervention design (N=250). As part of aim
2B), we will also systematically document and evaluate reasons for declining a PrEP referral, reasons for
incomplete referrals, reasons for failing to initiate PrEP after a successful referral, and ongoing PrEP use at
3/6 months post PrEP initiation among our sample. The proposed work will significantly contribute to our
understanding of factors impacting PrEP uptake and use among AA women at high-risk for HIV-infection,
particularly in underserved, rural areas in the Deep South that are increasingly impacted by the HIV epidemic
and have worse health outcomes relative to other areas in the US. The results of this work will also directly
contribute to a full-scale, R01-level cluster randomized implementation trial in which we will measure the
effectiveness and cost associated with a PrEP services delivery intervention serving AA women at-risk for
HIV-infection in primary care and reproductive health centers in rural areas of the Deep South.
项目摘要
生活在南方腹地的非洲裔美国人(AA)妇女感染艾滋病毒的可能性是美国妇女的10倍。
白色女人。传统的艾滋病毒预防方法,包括性传播感染/艾滋病毒教育、全面的行为
干预措施和提供避孕套在这一人群中取得的成功微乎其微。HIV暴露前
PrEP已经成为一种很有前途的生物医学预防工具,其疗效超过90%,
无数的审判。PrEP有可能遏制高危妇女的艾滋病毒感染事件;然而,
美国的生物医学艾滋病预防工作通常集中在男男性行为者身上,
妇女(特别是少数种族/族裔妇女)得不到充分服务,
艾滋病毒感染问题没有得到充分解决。实施科学项目迫切需要评估
并克服这一人群对PrEP的认识、吸收、坚持和坚持的障碍。的
这项应用的目的是增加农村地区有艾滋病毒感染风险的AA妇女的PrEP摄入
南部,特别是那些在亚拉巴马农村地区的联邦合格医疗中心(FQHC)寻求护理的人。
我们将使用混合方法的方法来适应和试点测试的病人提供者的沟通工具,
CDC PrEP工具包,侧重于PrEP级联的前三个步骤(例如,认识到艾滋病毒的风险,
确定为PrEP候选人,并对PrEP感兴趣),以通过转介到当地PrEP来增加PrEP吸收
诊所。具体而言,我们建议:(1)探索最近使用PrEP的AA妇女的艾滋病毒风险感知
(N=15-25),作为PrEP候选人的AA女性(N=15-25)和提供者(N=20),并确定
关于艾滋病毒风险和PrEP服务的患者-提供者沟通的偏好,
AA妇女的需求;(2A)系统地调整患者-提供者沟通工具,以增加PrEP
在农村亚拉巴马的两个温室气体排放控制中心的吸收,使用迭代实施过程;和(2B)。评估
可行性,可接受性,以及对PrEP的患者-提供者沟通干预的初步影响
AA妇女及其提供者在试点前/后干预设计中的吸收(N=250)。作为目标的一部分,
2B),我们还将系统地记录和评估拒绝PrEP转诊的原因,
不完整的转诊,成功转诊后未能启动PrEP的原因,以及持续使用PrEP,
在我们的样本中,PrEP启动后3/6个月。拟议的工作将大大有助于我们
了解影响艾滋病毒感染高风险AA妇女接受和使用PrEP的因素,
特别是在服务不足的南方腹地的农村地区,这些地区越来越受到艾滋病毒流行的影响
与美国其他地区相比,健康状况更差。这项工作的结果也将直接
有助于一个全面的,R 01水平的集群随机实施试验,我们将衡量
与PrEP服务提供干预措施相关的有效性和成本,为面临以下风险的AA妇女提供服务:
南方腹地农村地区初级保健和生殖健康中心的艾滋病毒感染。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MIRJAM-COLETTE KEMPF其他文献
MIRJAM-COLETTE KEMPF的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MIRJAM-COLETTE KEMPF', 18)}}的其他基金
PrEP Demonstration Project among Women at Risk for HIV Infection
针对艾滋病毒感染风险女性的 PrEP 示范项目
- 批准号:
10198705 - 财政年份:2019
- 资助金额:
$ 23.71万 - 项目类别:
Innovation Fund Application to the Multicenter AIDS Cohort Study MACS/Women's Interagency HIV Study WIHS Combined Cohort Study-MWCCS: COVID-19 Vaccine Acceptance and Hesitancy (CVHB) Study in People w
创新基金申请多中心艾滋病队列研究 MACS/妇女机构间艾滋病毒研究 WIHS 联合队列研究-MWCCS:人群中的 COVID-19 疫苗接受和犹豫 (CVHB) 研究
- 批准号:
10391742 - 财政年份:2019
- 资助金额:
$ 23.71万 - 项目类别:
Telemedicine to Improve Depression and Adherence in HIV+ Women in the Rural South
远程医疗可改善南方农村地区艾滋病毒妇女的抑郁症和依从性
- 批准号:
8330131 - 财政年份:2012
- 资助金额:
$ 23.71万 - 项目类别:
Telemedicine to Improve Depression and Adherence in HIV+ Women in the Rural South
远程医疗可改善南方农村地区艾滋病毒妇女的抑郁症和依从性
- 批准号:
8644945 - 财政年份:2012
- 资助金额:
$ 23.71万 - 项目类别:
Telemedicine to Improve Depression and Adherence in HIV+ Women in the Rural South
远程医疗可改善南方农村地区艾滋病毒妇女的抑郁症和依从性
- 批准号:
8469090 - 财政年份:2012
- 资助金额:
$ 23.71万 - 项目类别:
Telemedicine to Improve Depression and Adherence in HIV+ Women in the Rural South
远程医疗可改善南方农村地区艾滋病毒妇女的抑郁症和依从性
- 批准号:
8864139 - 财政年份:2012
- 资助金额:
$ 23.71万 - 项目类别:
相似海外基金
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
- 批准号:
10594350 - 财政年份:2023
- 资助金额:
$ 23.71万 - 项目类别:
Evaluating Centralizing Interventions to Address Low Adherence to Lung Cancer Screening Follow-up in Decentralized Settings
评估集中干预措施,以解决分散环境中肺癌筛查随访依从性低的问题
- 批准号:
10738120 - 财政年份:2023
- 资助金额:
$ 23.71万 - 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
- 批准号:
10526768 - 财政年份:2022
- 资助金额:
$ 23.71万 - 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
- 批准号:
10701072 - 财政年份:2022
- 资助金额:
$ 23.71万 - 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
- 批准号:
10679092 - 财政年份:2021
- 资助金额:
$ 23.71万 - 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
- 批准号:
10432133 - 财政年份:2021
- 资助金额:
$ 23.71万 - 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
- 批准号:
10327065 - 财政年份:2021
- 资助金额:
$ 23.71万 - 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
- 批准号:
10377366 - 财政年份:2019
- 资助金额:
$ 23.71万 - 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
- 批准号:
10574496 - 财政年份:2019
- 资助金额:
$ 23.71万 - 项目类别:
Targeted interventions to address the multi-level effects of gender-based violence on PrEP uptake and adherence among adolescent girls and young women in Kenya
有针对性的干预措施,以解决性别暴力对肯尼亚少女和年轻妇女接受和坚持 PrEP 的多层面影响
- 批准号:
9403567 - 财政年份:2017
- 资助金额:
$ 23.71万 - 项目类别: